{"id":4802,"date":"2020-03-26T08:20:38","date_gmt":"2020-03-26T08:20:38","guid":{"rendered":"https:\/\/be.alfasigma.com\/alfasigma-in-een-oogopslag\/"},"modified":"2021-12-16T17:03:35","modified_gmt":"2021-12-16T17:03:35","slug":"alfasigma-en-bref","status":"publish","type":"page","link":"https:\/\/be.alfasigma.com\/fr\/a-propos-de-nous\/alfasigma-en-bref\/","title":{"rendered":"ALFASIGMA en bref"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

A propos de nous \/ ALFASIGMA en bref<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Pharmaceuticals
with passion<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Alfasigma est l\u2019une des 5 premi\u00e8res entreprises pharmaceutiques en Italie, avec un chiffre d\u2019affaires en 2019 de plus d\u2019un milliard d\u2019euros. Il s\u2019agit d\u2019une soci\u00e9t\u00e9 \u00e0 capitaux priv\u00e9s dont 75% des parts sont d\u00e9tenues par la famille du fondateur et 25% par deux fonds.<\/span><\/p>\n

L\u2019h\u00e9ritage Alfasigma est solidement ancr\u00e9 gr\u00e2ce \u00e0 une \u00e8re d\u2019innovation et de succ\u00e8s, qui a vu le jour en 1948 \u00e0 Bologne (Italie) \u00e0 l\u2019initiative de Marino Golinelli, philanthrope de 100 ans.<\/p>\n

Depuis le d\u00e9but, Alfasigma a toujours suivi une double strat\u00e9gie :
 \u2022 En interne, un fort accent est mis sur la Recherche et le D\u00e9veloppement et la fabrication de mol\u00e9cules dont la soci\u00e9t\u00e9 est propri\u00e9taire, certaines repr\u00e9sentant plus de 50% des ventes ;
 \u2022 En externe, une strat\u00e9gie robuste de fusions et acquisitions d\u2019autres entreprises italiennes et internationales (Sigma Tau, Pamlabs) est d\u00e9velopp\u00e9e
Actuellement Alfasigma compte plus de 3. 000 employ\u00e9s dans le monde, 17 filiales et \u2013 par l\u2019interm\u00e9diaire de distributeurs de premier plan \u2013 sa pr\u00e9sence s\u2019\u00e9tend sur plus de 70 pays.<\/p>\n

<\/p>\n

Alfasigma Belgium est une filiale du groupe pharmaceutique international Alfasigma.<\/p>\n

Les bureaux d\u2019Alfasigma Belgium sont situ\u00e9s \u00e0 Bruxelles au coeur du \u201cRoyal Depot\u201d du site de Tour et Taxis

Alfasigma Belgium repose sur une \u00e9quipe de collaborateurs professionnels, dynamiques, motiv\u00e9s impliqu\u00e9s dans l\u2019accompagnement des patients, des professionnels de sant\u00e9, en collaboration avec les autorit\u00e9s de sant\u00e9 dans une d\u00e9marche de dialogue afin d\u2019apporter aux parties prenantes les solutions th\u00e9rapeutiques les plus adapt\u00e9es.<\/span><\/p>\n

Alfasigma Belgium distribue des sp\u00e9cialit\u00e9s pharmaceutiques, des nutraceutiques et des dispositifs m\u00e9dicaux issus de la recherche de la maison-m\u00e8re Italienne Alfasigma S.p.A et mais aussi de titulaires d\u2019Autorisation de Mise sur le March\u00e9 (AMM) tiers qui nous renouvellent leur confiance ann\u00e9e apr\u00e8s ann\u00e9e.<\/p>\n

Alfasigma Belgium est plus particuli\u00e8rement investie en la gyn\u00e9cologie, l\u2019urologie, la phl\u00e9bologie, la psychiatrie et les d\u00e9sordres m\u00e9taboliques.<\/p>\n

Nos activit\u00e9s sont men\u00e9es avec l\u2019objectif d\u2019offrir des produits et services de grande qualit\u00e9.<\/p>\n

L\u2019ensemble de l\u2019\u00e9quipe s\u2019engage \u00e0 d\u00e9livrer une information rigoureuse et \u00e0 former et accompagner les professionnels de sant\u00e9 \u00e0 l\u2019utilisation optimale des produits distribu\u00e9s. <\/p>\n

Passion, rigueur et expertise animent les collaborateurs qui visent l\u2019excellence.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Read More<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Company Profile
\nPDF - 7.4 MB<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g>\t\t\t<\/path>\t\t<\/path>\t\t<\/path>\t<\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/g><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Couverture g\u00e9ographique<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>

filiales<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>

distributeurs<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

70<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

distributeurs<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

17<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

filiales<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Belgique
Chine
R\u00e9publique tch\u00e8que
France
Inde
Italie
Mexique
Pays-Bas
Pologne<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Portugal
Roumanie
Russie
Slovaquie
Espagne
Suisse
Tunisie
\u00c9tats-Unis<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Business Unit \u2013 Contract Manufacturing<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tParall\u00e8lement \u00e0 ses activit\u00e9s traditionnelles, l\u2019entreprise joue \u00e9galement un r\u00f4le de premier plan en fournissant ses services \u00e0 d\u2019autres multinationales et soci\u00e9t\u00e9s pharmaceutiques italiennes gr\u00e2ce \u00e0 sa division Contract manufacturing, en croissance constante depuis 2017 avec un TCAC (TCAC Taux de Croissance Annuel Compos\u00e9 : CAGR Compound Annual Growth Rate) de 10,2%.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Chiffre d\u2019affaires<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\u20ac 989<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

milliards d\u2019euros en 2020<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

51% du Chiffre d\u2019Affaires est r\u00e9alis\u00e9 via 5 mol\u00e9cules propri\u00e9taires<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n
\n \n \n <\/div>
<\/div>\n <\/div>\n <\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

2018<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n
\n \n \n <\/div>
<\/div>\n <\/div>\n <\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

2019<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n
\n \n \n <\/div>
<\/div>\n <\/div>\n <\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

2020<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>

2<\/h3>

centres de R&D<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>

5<\/h3>

Usines de fabrication<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>

25<\/h3>

bureaux dans le monde<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Effectif<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>

2900<\/h3>

collaborateurs<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>

1700<\/h3>

en Italie<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>

1200<\/h3>

\u00e0 l\u2019International<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>

51%<\/h3>

d\u2019hommes<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>

49%<\/h3>

de femmes<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Collaborateurs (hors d\u2019Italie)<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\n
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Plus d'infos<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\n\t\t\t\t\t
\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Notre h\u00e9ritage<\/a><\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Alfasigma est n\u00e9e de la fusion d’Alfa Wassermann et de Sigma-Tau et a acquis plus de 60 ans d\u2019exp\u00e9rience dans l’industrie pharmaceutique.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\n\t\t\t\t\t
\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Leadership Model<\/a><\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

En 2019, Alfasigma a lanc\u00e9 un nouveau mod\u00e8le de Leadership o\u00f9 5 piliers constituent la base de nos activit\u00e9s quotidiennes.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\n\t\t\t\t\t
\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Notre objectif<\/a><\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tNotre objectif vise une meilleure sant\u00e9 et une meilleure qualit\u00e9 de vie pour les patients, les soignants et les fournisseurs de soins de sant\u00e9. \t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

A propos de nous \/ ALFASIGMA en bref Pharmaceuticals with passion Alfasigma est l\u2019une des 5 premi\u00e8res entreprises pharmaceutiques en Italie, avec un chiffre d\u2019affaires en 2019 de plus d\u2019un milliard d\u2019euros. Il s\u2019agit d\u2019une soci\u00e9t\u00e9 \u00e0 capitaux priv\u00e9s dont 75% des parts sont d\u00e9tenues par la famille du fondateur et 25% par deux fonds. … Continued<\/a><\/p>\n","protected":false},"author":1,"featured_media":4534,"parent":4799,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"views\/template-custom.blade.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-4802","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nAlfasigma BE - ALFASIGMA en bref<\/title>\n<meta name=\"robots\" content=\"index,follow\" \/>\n<link rel=\"canonical\" href=\"https:\/\/be.alfasigma.com\/fr\/a-propos-de-nous\/alfasigma-en-bref\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alfasigma BE - ALFASIGMA en bref\" \/>\n<meta property=\"og:description\" content=\"A propos de nous \/ ALFASIGMA en bref Pharmaceuticals with passion Alfasigma est l\u2019une des 5 premi\u00e8res entreprises pharmaceutiques en Italie, avec un chiffre d\u2019affaires en 2019 de plus d\u2019un milliard d\u2019euros. Il s\u2019agit d\u2019une soci\u00e9t\u00e9 \u00e0 capitaux priv\u00e9s dont 75% des parts sont d\u00e9tenues par la famille du fondateur et 25% par deux fonds. … Continued\" \/>\n<meta property=\"og:url\" content=\"https:\/\/be.alfasigma.com\/fr\/a-propos-de-nous\/alfasigma-en-bref\/\" \/>\n<meta property=\"og:site_name\" content=\"Alfasigma BE\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-16T17:03:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/be.alfasigma.com\/wp-content\/uploads\/2020\/07\/ALANNO_1044_FOTO_NICCOLO_BIDDAU-dida-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/fr\\\/a-propos-de-nous\\\/alfasigma-en-bref\\\/\",\"url\":\"https:\\\/\\\/be.alfasigma.com\\\/fr\\\/a-propos-de-nous\\\/alfasigma-en-bref\\\/\",\"name\":\"Alfasigma BE - ALFASIGMA en bref\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/fr\\\/a-propos-de-nous\\\/alfasigma-en-bref\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/fr\\\/a-propos-de-nous\\\/alfasigma-en-bref\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/be.alfasigma.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/ALANNO_1044_FOTO_NICCOLO_BIDDAU-dida-1.jpg\",\"datePublished\":\"2020-03-26T08:20:38+00:00\",\"dateModified\":\"2021-12-16T17:03:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/fr\\\/a-propos-de-nous\\\/alfasigma-en-bref\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/be.alfasigma.com\\\/fr\\\/a-propos-de-nous\\\/alfasigma-en-bref\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/fr\\\/a-propos-de-nous\\\/alfasigma-en-bref\\\/#primaryimage\",\"url\":\"https:\\\/\\\/be.alfasigma.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/ALANNO_1044_FOTO_NICCOLO_BIDDAU-dida-1.jpg\",\"contentUrl\":\"https:\\\/\\\/be.alfasigma.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/ALANNO_1044_FOTO_NICCOLO_BIDDAU-dida-1.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/fr\\\/a-propos-de-nous\\\/alfasigma-en-bref\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/be.alfasigma.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A propos de nous\",\"item\":\"https:\\\/\\\/be.alfasigma.com\\\/fr\\\/a-propos-de-nous\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"ALFASIGMA en bref\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/\",\"name\":\"Alfasigma BE\",\"description\":\"Pharmaceuticals with passion\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alfasigma BE - ALFASIGMA en bref","robots":{"index,follow":"index,follow"},"canonical":"https:\/\/be.alfasigma.com\/fr\/a-propos-de-nous\/alfasigma-en-bref\/","og_locale":"fr_FR","og_type":"article","og_title":"Alfasigma BE - ALFASIGMA en bref","og_description":"A propos de nous \/ ALFASIGMA en bref Pharmaceuticals with passion Alfasigma est l\u2019une des 5 premi\u00e8res entreprises pharmaceutiques en Italie, avec un chiffre d\u2019affaires en 2019 de plus d\u2019un milliard d\u2019euros. Il s\u2019agit d\u2019une soci\u00e9t\u00e9 \u00e0 capitaux priv\u00e9s dont 75% des parts sont d\u00e9tenues par la famille du fondateur et 25% par deux fonds. … Continued","og_url":"https:\/\/be.alfasigma.com\/fr\/a-propos-de-nous\/alfasigma-en-bref\/","og_site_name":"Alfasigma BE","article_modified_time":"2021-12-16T17:03:35+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/be.alfasigma.com\/wp-content\/uploads\/2020\/07\/ALANNO_1044_FOTO_NICCOLO_BIDDAU-dida-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/be.alfasigma.com\/fr\/a-propos-de-nous\/alfasigma-en-bref\/","url":"https:\/\/be.alfasigma.com\/fr\/a-propos-de-nous\/alfasigma-en-bref\/","name":"Alfasigma BE - ALFASIGMA en bref","isPartOf":{"@id":"https:\/\/be.alfasigma.com\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/be.alfasigma.com\/fr\/a-propos-de-nous\/alfasigma-en-bref\/#primaryimage"},"image":{"@id":"https:\/\/be.alfasigma.com\/fr\/a-propos-de-nous\/alfasigma-en-bref\/#primaryimage"},"thumbnailUrl":"https:\/\/be.alfasigma.com\/wp-content\/uploads\/2020\/07\/ALANNO_1044_FOTO_NICCOLO_BIDDAU-dida-1.jpg","datePublished":"2020-03-26T08:20:38+00:00","dateModified":"2021-12-16T17:03:35+00:00","breadcrumb":{"@id":"https:\/\/be.alfasigma.com\/fr\/a-propos-de-nous\/alfasigma-en-bref\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/be.alfasigma.com\/fr\/a-propos-de-nous\/alfasigma-en-bref\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/be.alfasigma.com\/fr\/a-propos-de-nous\/alfasigma-en-bref\/#primaryimage","url":"https:\/\/be.alfasigma.com\/wp-content\/uploads\/2020\/07\/ALANNO_1044_FOTO_NICCOLO_BIDDAU-dida-1.jpg","contentUrl":"https:\/\/be.alfasigma.com\/wp-content\/uploads\/2020\/07\/ALANNO_1044_FOTO_NICCOLO_BIDDAU-dida-1.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/be.alfasigma.com\/fr\/a-propos-de-nous\/alfasigma-en-bref\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/be.alfasigma.com\/fr\/"},{"@type":"ListItem","position":2,"name":"A propos de nous","item":"https:\/\/be.alfasigma.com\/fr\/a-propos-de-nous\/"},{"@type":"ListItem","position":3,"name":"ALFASIGMA en bref"}]},{"@type":"WebSite","@id":"https:\/\/be.alfasigma.com\/nl\/#website","url":"https:\/\/be.alfasigma.com\/nl\/","name":"Alfasigma BE","description":"Pharmaceuticals with passion","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/be.alfasigma.com\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/be.alfasigma.com\/fr\/wp-json\/wp\/v2\/pages\/4802","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/be.alfasigma.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/be.alfasigma.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/be.alfasigma.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/be.alfasigma.com\/fr\/wp-json\/wp\/v2\/comments?post=4802"}],"version-history":[{"count":84,"href":"https:\/\/be.alfasigma.com\/fr\/wp-json\/wp\/v2\/pages\/4802\/revisions"}],"predecessor-version":[{"id":6011,"href":"https:\/\/be.alfasigma.com\/fr\/wp-json\/wp\/v2\/pages\/4802\/revisions\/6011"}],"up":[{"embeddable":true,"href":"https:\/\/be.alfasigma.com\/fr\/wp-json\/wp\/v2\/pages\/4799"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/be.alfasigma.com\/fr\/wp-json\/wp\/v2\/media\/4534"}],"wp:attachment":[{"href":"https:\/\/be.alfasigma.com\/fr\/wp-json\/wp\/v2\/media?parent=4802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}